PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-12-12

Date Title Company
12-Dec-2021 MorphoSys presents latest data from the Phase 2 MANIFEST Study evaluating the potential of pelabresib in the treatment of myelofibrosis MorphoSys AG